Pharmaceutical Company
Provide advice and strategic counsel with regard to regulations that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Care Reform, Medicaid, 340b, FDA regulatory issues, and corporate tax reform.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BGR GOVERNMENT AFFAIRS
601 13th Street, NW, 11th Floor South, Washington, DC, 20005, US
REMY LEIGH BRIM MASON (See prior filing) ROBERT WOOD (See prior filing) BRENT ALAN DEL MONTE (See prior filing) ROBB WALTON (See prior filing) JOHN STONE (See prior filing) MATT HOFFMANN (See prior filing)
See prior filing See prior filing See prior filing See prior filing See prior filing See prior filing